Why the study?
To achieve better long-term clinical outcomes following drug-eluting stent implantation, further titration of drug-release and polymer degradation profiles, strut thickness, and material innovations are needed.
Further innovations in stent design and materials are required to improve long-term clinical outcomes and reduce in-stent restenosis in patients receiving drug-eluting stents.
: The initial drawbacks of first-generation DES, such as delayed endothelial healing and subsequent risk of late stent thrombosis, have been improved upon by the current generation DES. To achieve better long-term clinical outcomes, further titration of drug-release and polymer degradation profile, strut thickness as well as material innovation are needed.
No takes yet. Share an insight, caveat, or question.
Sakamoto et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: